Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Magnachip Semiconductor Gets a Boost From Lakewood Capital

Magnachip Semiconductor just got a boost from this hedgie. In a 13G filing with the Securities and Exchange Commission, Anthony Bozza‘s hedge fund Lakewood Capital Management, disclosed increasing its stake in Magnachip Semiconductor Corp (NYSE:MX) by 813,900 shares, to more than 1.9 million shares. At the current price of Magnachip’s stock, the value of Lakewood’s position in the company amounts to almost $42.4 million.

Magnachip Semiconductor Corp (NYSE:MX)

Through the increase of its position on Magnachip Semiconductor, Lakewood Capital continues to be bullish on the company, after initiating the position during the previous quarter. According to the latest 13F filing with the SEC, Anthony Bozza’s hedge fund first disclosed ownership of slightly below 1.1 million shares. The move comes amid the recent sale of 1.7 million shares of Magnachip Semiconductor made by a director fund, Avenue Special Situations Fund IV LP.

At the same time, we should mention some other bullish firms that disclosed ownership of Magnachip Semiconductor Corp. As follows, according to our database of 13F filings, the hedge fund with the largest stake in the company is Avenue Capital, managed by Marc Lasry that held around 7.5 million shares at the end of the previous quarter. Other hedge funds worth mentioning while speaking about Magnachip Semiconductor are: Steven Cohen’s Sac Capital Advisors, Joseph A. Jolson’s Harvest Capital Strategies, and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Recommended Reading:

Steadfast Capital’s Stake in YY Inc (ADR) (YY) Surges

Immersion, Navidea Biopharmaceuticals & More Picks From This $58 Billion Hedge Fund Company

Carl Icahn’s Primetime Position On The Fed, Apple Inc. (AAPL)’s ‘No Brainer’ & Bill Ackman

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!